Home/Pipeline/ArthroCart

ArthroCart

Knee Osteoarthritis

PreclinicalActive

Key Facts

Indication

Knee Osteoarthritis

Phase

Preclinical

Status

Active

Company

About Arthro Biotech

Indian biotech advancing stem‑cell‑based regenerative therapies for orthopedic disorders.

View full company profile

Therapeutic Areas

Orthopedics Regenerative Medicine

Other Knee Osteoarthritis Drugs

Drug	Company	Phase	Status
Progenza	Cambium Bio	Phase 1/2a	Active
MAG200	Magellan	Phase 3	Active
MUTI™ Knee Replacement	Meril	Commercial	Active
DUROLANE	Bioventus	Commercial	Active
XSTEM	Xintela	Phase I/IIa	Completed (Results Reported)
Stempeucel®	Stempeutics Research	Commercial	Approved
Lipogems System for Knee Osteoarthritis	Lipogems International	Phase 3	Active
Signature Cord Prime™	Arugula Sciences	Phase 1	Active
Knee Osteoarthritis Study	Arizona Research Center	Not Specified	Active - Enrolling
4P004	4Moving Biotech	Phase 2a	Active
Lorecivivint (inferred)	Biosplice Therapeutics	Phase 3	Active
Regenerative Cell Therapy for Osteoarthritis	InGeneron	Phase 3	Active